These results show that fractionated radiotherapy combined with anti-CTLA-4 antibody had a greater efficacy in treating breast tumors, with increased production of IFN-γ and smaller tumor volumes, surpassing the effectiveness of single-dose radiation therapy in combination with anti-CTLA-4 antibody. This evidence concerns the gene IFNG and breast neoplasm.